[Epidemiological characteristics of hemorrhoids in a healthy physical examination population in China].


Journal

Beijing da xue xue bao. Yi xue ban = Journal of Peking University. Health sciences
ISSN: 1671-167X
Titre abrégé: Beijing Da Xue Xue Bao Yi Xue Ban
Pays: China
ID NLM: 101125284

Informations de publication

Date de publication:
18 Oct 2024
Historique:
medline: 14 10 2024
pubmed: 14 10 2024
entrez: 14 10 2024
Statut: ppublish

Résumé

To describe the epidemiological distribution of hemorrhoids in a physical examination population in China, which could provide evidence for precision prevention and early intervention of hemorrhoids. Chinese subjects over 18 years of age who underwent a physical examination in a nationwide chain of physical examination centers in 2018 were studied in a cross-sectional design, which collected information by a questionnaire and physical examination results from each subject. The epidemiological distribution of hemorrhoids was described using Logistic models. The gender-, age-, and region-detection rates of hemorrhoids were standardized to the Sixth National Population Census of the People's Republic of China (2010). A total of 2 940 295 adult subjects were included in the study, of whom the average age was (41.7±14.0) years, and 52.6% were females. The standardized detection rate of hemorrhoids was higher for females (43.7%) than that for males (17.7%; The detection rate of hemorrhoids varied to gender, age, obesity, and hypertension status, which could help to identify the risk factors and the high-risk sub-groups, and hence to strengthen health education and early detection accordingly, which could eventually reduce the incidence of hemorrhoids and improve the quality of life and health in the Chinese population. This study was conducted in a physical examination population, and the conclusions of this study should be extrapolated with caution.

Identifiants

pubmed: 39397459

Types de publication

English Abstract Journal Article

Langues

chi

Sous-ensembles de citation

IM

Pagination

815-819

Auteurs

Chenghua Guo (C)

Department of Epidemiology and Biostatistics, Peking University School of Public Health, Beijing 100191, China.

Xiaoyu Che (X)

Department of Epidemiology and Biostatistics, Peking University School of Public Health, Beijing 100191, China.

Zhi Lin (Z)

Department of Epidemiology and Biostatistics, Peking University School of Public Health, Beijing 100191, China.

Shan Cai (S)

Department of Epidemiology and Biostatistics, Peking University School of Public Health, Beijing 100191, China.

Guozhen Liu (G)

Beijing Institute of Big Data Research & PKU Healthcare IT Company Big Data Laboratory, Beijing 100080, China.

Lang Pan (L)

Peking University Center for Public Health and Epidemic Preparedness Response, Beijing 100191, China.

Jun Lv (J)

Department of Epidemiology and Biostatistics, Peking University School of Public Health, Beijing 100191, China.
Peking University Center for Public Health and Epidemic Preparedness Response, Beijing 100191, China.
Key Laboratory of Epidemiology of Major Diseases (Peking University), Ministry of Education, Beijing 100191, China.

Liming Li (L)

Department of Epidemiology and Biostatistics, Peking University School of Public Health, Beijing 100191, China.
Peking University Center for Public Health and Epidemic Preparedness Response, Beijing 100191, China.
Key Laboratory of Epidemiology of Major Diseases (Peking University), Ministry of Education, Beijing 100191, China.

Sailimai Man (S)

Mei-nian Public Health Research Institute, Peking University Health Science Center, Beijing 100191, China.

Bo Wang (B)

Mei-nian Public Health Research Institute, Peking University Health Science Center, Beijing 100191, China.

Canqing Yu (C)

Department of Epidemiology and Biostatistics, Peking University School of Public Health, Beijing 100191, China.
Peking University Center for Public Health and Epidemic Preparedness Response, Beijing 100191, China.
Key Laboratory of Epidemiology of Major Diseases (Peking University), Ministry of Education, Beijing 100191, China.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH